Avanos Medical, Inc. (NYSE: AVNS) reported Q4 EPS of $0.43, $0.03 better than the analyst estimate of $0.40. Revenue for the quarter came in at $179.6 million versus the consensus estimate of $177.23 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2025 EPS of $1.05-$1.25, versus the consensus of $1.67.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.